Giostar: claims, evidence and regulatory questions
A neutral review framework based on provider-published information and official regulator sources. It is not an endorsement, accusation or substitute for independent medical advice.
GIOSTAR-branded websites describe regenerative-medicine services in more than one country; the Mexico provider website is one current example. Brand affiliation does not establish that every location, product or indication has the same legal status, manufacturing process or evidence. Verify the exact treating entity and jurisdiction rather than relying on the brand name.
Request the product name, cell source, processing, manufacturer, dose, route, indication and current authority reference for the selected location. For Mexico, confirm records with COFEPRIS; for any other country, use its competent authority. Ask for trial documents, complete results, consent, insurance and follow-up, and do not treat testimonials or package price as evidence.
| Check | What to request from Giostar | Independent verification |
|---|---|---|
| Operating entity and location | Current legal name, address and treating clinician | National provider or professional register |
| Exact intervention | Product name, cell source, processing, dose and route | Regulator product record and authorised indication |
| Legal route | Marketing authorisation, authorised trial, or named exemption | Confirmation from the competent authority |
| Manufacturing | Manufacturer, site and authorisation scope | Current authority record applicable to that product |
| Evidence | Protocol, trial identifier and complete results | Registry status, peer-reviewed publication and regulator assessment |
| Patient protection | Consent, harms, insurance, emergency and follow-up plans | Independent clinician and ethics/regulatory documents |
| Cost | Dated, itemised written quote and refund terms | Do not treat price as evidence of approval or benefit |
Common questions
Does a clinic licence mean every cell product it offers is authorised?
No. A facility, clinician, tissue establishment, manufacturer and medicinal product can be regulated under different legal routes. Ask the relevant authority to confirm the exact product, indication and route.
Does a trial or registry listing prove that a treatment works?
No. Registration improves transparency but does not establish efficacy, marketing authorisation or lawful commercial supply. Review the protocol, sponsor, regulatory authorisation, status and results separately.
How should I compare cell-therapy providers?
Compare the exact product and indication, legal route, manufacturing authorisation, peer-reviewed evidence, consent and adverse-event safeguards, follow-up plan and a dated itemised quote. Do not compare broad labels such as 'stem cells' alone.
Sources & further reading
- Stem-cell trials registry (ClinicalTrials.gov) ↗
- Peer-reviewed research (PubMed) ↗
- ISSCR — patient resources ↗
- FDA — consumer guidance ↗
- EMA — ATMP framework ↗
Provider information reviewed in 2026 and may change. Verify current records directly with the relevant authority. Not medical advice.